Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.

Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H.

Br J Cancer. 2001 Mar 2;84(5):704-8.

2.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
3.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
4.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Welcsh PL, King MC.

Hum Mol Genet. 2001 Apr;10(7):705-13. Review.

PMID:
11257103
5.

Genes implicated in hereditary breast cancer syndromes.

Tonin PN.

Semin Surg Oncol. 2000 Jun;18(4):281-6. Review.

PMID:
10805949
6.

[Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].

Ruiz-Flores P, Calderón-Garcidueñas AL, Barrera-Saldaña HA.

Rev Invest Clin. 2001 Jan-Feb;53(1):46-64. Review. Spanish.

PMID:
11332051
7.

Hereditary breast cancer: a review.

Arver B, Du Q, Chen J, Luo L, Lindblom A.

Semin Cancer Biol. 2000 Aug;10(4):271-88. Review.

PMID:
10966850
8.

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.

Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE, et al.

Nat Med. 1996 Nov;2(11):1179-83. Review. No abstract available.

PMID:
8898735
9.

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.

Verhoog LC, Berns EM, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):119S-24S. Review.

PMID:
11060339
10.

Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2.

Berchuck A, Carney M, Lancaster JM, Marks J, Futreal AP.

Clin Obstet Gynecol. 1998 Mar;41(1):157-66. Review. No abstract available.

PMID:
9504233
11.

Is TP53 dysfunction required for BRCA1-associated carcinogenesis?

Schuyer M, Berns EM.

Mol Cell Endocrinol. 1999 Sep 10;155(1-2):143-52. Review.

PMID:
10580847
12.

Laboratory identification of hereditary risk of breast and ovarian cancer.

Frank TS.

Curr Opin Biotechnol. 1999 Jun;10(3):289-94. Review. No abstract available.

PMID:
10361081
13.

Hereditary and sporadic ovarian cancer: genetic testing and clinical implications (review).

Angioli R, Estape R, Mason M, Penalver M.

Int J Oncol. 1998 May;12(5):1029-34. Review.

PMID:
9538124
14.

Testing for inherited susceptibility to breast and ovarian cancer.

Brunner HG, Ligtenberg MJ.

Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):143-6. Review. No abstract available.

PMID:
10206405
15.

Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.

Phillips KA.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):107S-12S. Review.

PMID:
11060337
16.

Breast cancer genes: therapeutic strategies.

Holt JT.

Ann N Y Acad Sci. 1997 Dec 29;833:34-41. Review.

PMID:
9616738
17.

BRCA1 and BRCA2--breast cancer susceptibility genes.

Hofmann W, Schlag PM.

J Cancer Res Clin Oncol. 2000 Sep;126(9):487-96. Review.

PMID:
11003560
18.

Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer.

Robson M.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):113S-8S. Review.

PMID:
11060338
19.

[Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy].

Levanat S, Cvok ML.

Lijec Vjesn. 2010 Jan-Feb;132(1-2):34-7. Review. Croatian.

PMID:
20359158
20.

A review of hereditary breast cancer: from screening to risk factor modification.

Warmuth MA, Sutton LM, Winer EP.

Am J Med. 1997 Apr;102(4):407-15. Review.

PMID:
9217624

Supplemental Content

Support Center